NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Daniel G. Coit, John A. Thompson, Alain Algazi, Robert Andtbacka, Christopher K. Bichakjian, William E.Carson Iii, Gregory A. Daniels, Dominick Dimaio, Ryan C. Fields, Martin D. Fleming, Brian Gastman, Rene Gonzalez, Valerie Guild, Douglas Johnson, Richard W. Joseph, Julie R. Lange, Mary C. Martini, Miguel A. Materin, Anthony J. Olszanski, Patrick OttAparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Susan M. Swetter, Kenneth K. Tanabe, Javier F. Torres-Roca, Vijay Trisal, Marshall M. Urist, Nicole McMillian, Anita Engh

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Abstract

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.

Original languageEnglish
Pages (from-to)945-958
Number of pages14
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Dive into the research topics of 'NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines'. Together they form a unique fingerprint.

Cite this